midazolam has been researched along with Developmental Disabilities in 6 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "All had developmental delay (66." | 5.62 | The Use of Oral Midazolam to Facilitate the Ophthalmic Examination of Children with Autism and Developmental Disorders. ( Comer, G; Flanagan, O; McBride, GR; Stephenson, KAJ, 2021) |
| "All had developmental delay (66." | 1.62 | The Use of Oral Midazolam to Facilitate the Ophthalmic Examination of Children with Autism and Developmental Disorders. ( Comer, G; Flanagan, O; McBride, GR; Stephenson, KAJ, 2021) |
| " Medication dosing generally followed standard dosing guidelines with very few exceptions." | 1.51 | Seizure Rescue Medication Use among US Pediatric Epilepsy Providers: A Survey of the Pediatric Epilepsy Research Consortium. ( Payne, E; Wallace, A; Wirrell, E, 2019) |
| "Midazolam exposure was associated with macro- and microstructural alterations in hippocampal development and poorer outcomes consistent with hippocampal dysmaturation." | 1.43 | Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants. ( Chakravarty, MM; Chau, V; Dodbiba, L; Duerden, EG; Grunau, RE; Guo, T; Miller, SP; Poskitt, KJ; Synnes, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, R | 1 |
| Hori, H | 1 |
| Iida, H | 1 |
| Kawasaki, H | 1 |
| McBride, GR | 1 |
| Stephenson, KAJ | 1 |
| Comer, G | 1 |
| Flanagan, O | 1 |
| Xu, J | 1 |
| Mathena, RP | 1 |
| Singh, S | 1 |
| Kim, J | 1 |
| Long, JJ | 1 |
| Li, Q | 1 |
| Junn, S | 1 |
| Blaize, E | 1 |
| Mintz, CD | 1 |
| Wallace, A | 1 |
| Wirrell, E | 1 |
| Payne, E | 1 |
| Duerden, EG | 1 |
| Guo, T | 1 |
| Dodbiba, L | 1 |
| Chakravarty, MM | 1 |
| Chau, V | 1 |
| Poskitt, KJ | 1 |
| Synnes, A | 1 |
| Grunau, RE | 1 |
| Miller, SP | 1 |
| Casado, AI | 1 |
| Ruiz, J | 1 |
| Oro, J | 1 |
| MartÃnez, C | 1 |
| Fernández, I | 1 |
| Oliva, P | 1 |
6 other studies available for midazolam and Developmental Disabilities
| Article | Year |
|---|---|
Benzodiazepine withdrawal catatonia after discontinuing midazolam in young patient with intellectual developmental disorder: A case report.
Topics: Adult; Benzodiazepines; Catatonia; Developmental Disabilities; Humans; Intellectual Disability; Male | 2023 |
The Use of Oral Midazolam to Facilitate the Ophthalmic Examination of Children with Autism and Developmental Disorders.
Topics: Administration, Oral; Autistic Disorder; Child; Child, Preschool; Cohort Studies; Conscious Sedation | 2021 |
Early Developmental Exposure to Repetitive Long Duration of Midazolam Sedation Causes Behavioral and Synaptic Alterations in a Rodent Model of Neurodevelopment.
Topics: Aging; Animals; Behavior, Animal; Cells, Cultured; Conscious Sedation; Dentate Gyrus; Developmental | 2019 |
Seizure Rescue Medication Use among US Pediatric Epilepsy Providers: A Survey of the Pediatric Epilepsy Research Consortium.
Topics: Administration, Intranasal; Administration, Oral; Administration, Rectal; Adolescent; Age Factors; A | 2019 |
Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants.
Topics: Child Development; Developmental Disabilities; Dose-Response Relationship, Drug; Female; Follow-Up S | 2016 |
Anaesthetic management in a case of Kabuki syndrome.
Topics: Abnormalities, Multiple; Adjuvants, Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; A | 2004 |